| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Revenue | $2.1M | +35.2% |
| Cost of Revenue | $2.5M | +19.6% |
| Gross Profit | -$396K | +26.4% |
| R&D Expense | $359K | +7.6% |
| SG&A Expense | $3.2M | -18.4% |
| Operating Income | -$5.5M | -7.4% |
| Interest Expense | $91K | +236.4% |
| Pre-tax Income | -$6.0M | -9.6% |
| Income Tax | $7K |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105K | -26.1% |
| Accounts Receivable | $123K | -75.5% |
| Inventory | $119K | -41.6% |
| Current Assets | $7.1M | +66.5% |
| Total Assets | $12.2M | -5.0% |
| Current Liabilities | $13.7M | -52.3% |
| Long-term Debt | $21.5M | +636.8% |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | +27.7% |
| Investing Cash Flow | $777K | +1599.4% |
| Financing Cash Flow | $512K | -70.0% |
| — |
| Net Income | -$6.0M | -13.2% |
| EPS (Basic) | -$0.05 | -400.0% |
| EPS (Diluted) | -$0.05 | -400.0% |
| Total Liabilities |
| $35.2M |
| +11.6% |
| Stockholders' Equity | -$23.0M | -23.0% |